Q4 2025 Holdings
Filed 2026-02-13 | 14 holdings | $309.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pfizer Inc(PFE) | COM | 717081103 | $50.9M | 2,042,242 | 16.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $40.5M | 52,420 | 13.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $35.3M | 371,216 | 11.4% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $32.5M | 840,650 | 10.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $30.0M | 35,685 | 9.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $23.0M | 1,056,668 | 7.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $22.3M | 1,028,298 | 7.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $18.9M | 238,477 | 6.1% |
| Natera Inc(NTRA) | COM | 632307104 | $18.0M | 78,650 | 5.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $8.9M | 8,307 | 2.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $8.1M | 261,615 | 2.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.6M | 210,648 | 2.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $6.7M | 162,005 | 2.2% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $6.5M | 48,502 | 2.1% |